Elahe Mostaghel - Resistance To Ar Signaling Inhibitors In Castration Resistant Prostate Cancer

Elahe Mostaghel - Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer

Targeting AR in Castration Resistant Prostate Cancer

Grand Rounds in Urology

Androgen synthesis blockade - Abiraterone

Science in Motion

Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer

Grand Rounds in Urology

Epigenetic Drivers of Prostate Cancer

Cell Signaling Technology, Inc.

PARP inhibitors for the treatment of metastic castration-resistant prostate cancer

Androgen Receptor and Castration-Resistant Prostate Cancer

Emerging Strategies to Reverse Prostate Cancer Therapeutic Resistance

LurieCancerCenter

AR-V7 in Castration Resistant Prostate Cancer

Grand Rounds in Urology

Exploring the Complexities of Androgen Signaling in Prostate Cancer Progression - Eleni Efstathiou

The Society for Translational Oncology

Larry Karsh - How do I choose Androgen Biosynthesis Inhibitor, Androgen Receptor Antagonist, or both

FIH study of ARV-110 in metastatic castrate-resistant prostate cancer

Androgen Targeted Therapy Across the Continuum of Prostate Cancer

Grand Rounds in Urology

Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer

AR-Targeted Therapies in CRPC

Treatment sequencing for metastatic castration-resistant prostate cancer

AR V7 Predicts Response in CRPC

Grand Rounds in Urology

Dr. James Mohler on Androgen Signaling and Prostate Growth

Targeted Oncology

Prechemotherapy Treatment Strategies in Castration-Resistant Prostate Cancer

How to treat men with advanced castration resistant prostate cancer with AR directed therapy

European Society for Medical Oncology (ESMO)